Table 7.
Sensitive analysis by using new classification of hypertension (SBP > 130|DBP > 80)
| ALT levels (U/L) | Hypertensive, n (%) | Age-Sex-adjusted OR (95% CI) | Multi-adjusted OR (95% CI)* |
|---|---|---|---|
| Group I | |||
| 0–40 | 5,753,021 (30.86) | 1 | 1 |
| 40.01– | 1,091,213 (44.29) | 1.37 (1.36,1.37) | 1.17 (1.16,1.17) |
| Group II | |||
| 0–20 | 2,935,226 (27.37) | 1 | 1 |
| 20.01–40 | 2,817,795 (35.60) | 1.16 (1.16,1.16) | 1.09 (1.08,1.09) |
| 40.01–60 | 605,968 (43.36) | 1.42 (1.41,1.43) | 1.21 (1.20,1.21) |
| 60.01–80 | 239,252 (44.90) | 1.51 (1.50,1.52) | 1.22 (1.22,1.23) |
| 80.01– | 245,993 (46.11) | 1.60 (1.59,1.61) | 1.25 (1.25,1.26) |
| P for trend† | < 0.001 | < 0.001 |
ALT: alanine aminotransferase; OR: odds ratios; CI: confidence interval;
*Adjusted for age, sex, ethnicity, area, education, body mass index, average salt consumption, history of diabetes, overall pressure and hepatitis B surface antigen status;
†P for trend were calculated by set categorized ALT levels as a continuous variable